18-44 YOSHLI QISHLOQ AHOLISIDA ASOSIY YUQUMSIZ KASALLIKLAR EPIDEMIOLOGIYASI VA XAVFINING ERKAK VA AYOLLARDA TAVSIFI
Article Sidebar
Main Article Content
Аннотация:
Birlashgan Millatlar Tashkiloti sammitida (2015 y) 150 dan ortiq davolash yo‘lboshchilari ishtiroki bilan kelgusi 15 yil davomida birday rivojlanishga olib boruvchi 17 ta ambitsiozli maqsadlar e’lon qilingan va qabul etilgan. Ular orasida eng ahamiyatlisi «Butun umr davomida sog‘lom xayotni va ijtimoiy muvoffaqiyatni ta’minlash» deb nomlangan uchinchi maqsadni aloxida ajratish mumkin bo‘ladi. Bu maqsadga erishish dunyoda “sog‘lomlarni” sonini ko‘paytirishga erishishni ta’minlab beradi va/yoki umuman jami plonetananing axolisini xayotini yaxshilashga olib kelishi mumkin bo‘lgan sharoitlarni tuhdirib berish imkoniyatlari ortadi.
Article Details
Как цитировать:
Библиографические ссылки:
Крысанова В.С., Келехсаев П.А. Социально – экономические аспекты проблемы избыточной массы тела и ожиреня. Лечебное дело. 2020;3:100 - 106. doi: 10.24412/2071 - 5315 - 2020 - 12264.
Alshahrani NS, Hartley A, Howard J, Hajhosseiny R, Khawaja S, Selig- man H et al/ Randomized Trial of Remote Assessment of Patients Af¬ter an Acute Coronary Syndrome. Journal of the American College of Cardiology. 2024;83(23):2250-9. DOI: 10.1016/j jacc.2024.03.398.
Ayers JW, Poliak A, Dredze M, Leas EC, Zhu Z, Kelley JB et al. Com¬ paring Physician and Artificial Intelligence Chatbot Responses to Pa¬tient Questions Posted to a Public Social Media Forum. JAMA In¬ternal Medicine.2023; 183(6):589—96.DOI:10.1001/jamain-temmed.2023.1838. Bettcher D. Monitoring and surveillance of chronic non- communicable diseases: progress and capacity in high-burden countries. The Lancet. 2010;376(9755): 1861 -1868.doi: http.V/dx.doi.org/l 0.1016/SO 140-6736Г10)61853- 1
Boehmer JP, Cremer S, Abo-Auda WS, Stokes DR, Hadi A, Mc Cann PJ et al. Impact of a Novel Wearable Sensor on Heart Failure Rehospitalization:An Open-Label Concurrent-Control Clinical Tri¬al. JACC:Heart Failure.2024; 12(12):2011-22.DOI:10.1016/j.jchf.2024.07.022.
Hu J-R, Power JR, Zannad F, Lam CSP. Artificial intelligence and di¬gital tools for. design and execution of cardiovascular clinical trials. Eu¬ropean Heart Journal. 2024;ehae794. [Epub ahead of print]. DOI: 10.1093/eurheartj/ehae794.
Morley J, Murphy L, Mishra A, Joshi I, Karpathakis K. Gover¬ning Data and Artificial IntelligenceforHealth Care:Develo¬pingan International Understanding.JMIR Formative Research. 2022;6(l):e31623. DOI: 10.2196/31623.
Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digital Medicine. 2020;3(1 ):17. DOI: 10.103 8/s41746-020-0221-y.
Vandenbroucke F, Michel M, Ackerman N, Briganti G. L’adoption de l’lntelligence Artificielle dans les hopitaux en Belgique. Barometer. 2022 26p. Av. at:https://www.msdconnect.be/fr/wp-content/up-loads/sites/15/2022/05/FR_BarometreIA_ Belgique.pdf.
World Health Organization Media Centre. Obesity and overweight. Fact sheet no Geneva: World Health Organization, 2021.
Wrzeciono A, Cieslik B, Kiper P, Szczepanska-Gieracha J, Gajda R. Ex¬ploratory analysis of the effectiveness of virtual reality in cardiovascu-lar rehabilitation. Scientific Reports. 2024; 14(1 ):281. DOI:10.1038/s41598-023-50788-9.
Xu M, Xu J, Yang X. Asthma and risk of cardiovascular disease or all¬cause mortality: a meta-analysis. Annals of Saudi Medicine. 2017;37(2):99-105. https://doi.om/10.5144/0256-4947.2011.99